What if 'negotiation' brought down drug cost...
What would happen if drug price 'negotiation' brought down pharma list prices across the board? Not much at all, at least not for...
top of page
Vocal.
Search
Ulrich Neumann, MBA MSc MA
Oct 26, 20211 min
A $250B healthcare reform opportunity in three years: Reducing administrative complexity
New research by David Cuttler with McKinsey and Partners published in JAMA shows that there are $250B in healthcare savings annually....
Ulrich Neumann, MBA MSc MA
May 29, 20211 min
Memorial Day Patriotism
From NYC to Texas, the feeling going into this Memorial Day weekend is that we're finally done with COVID. But is the virus done with us?
Ulrich Neumann, MBA MSc MA
Oct 9, 201910 min
'ICER'​ strikes again - Scandal time?
The drug-price watchdog ICER just issued a "Report on Unsupported Price Increases". The 'study' made the headlines, but it is problematic.
Ulrich Neumann, MBA MSc MA
Nov 23, 20181 min
PharmaVoice 'Year in Preview'​- Interview
Thanks to the team at PharmaVoice for the interview for the "Year in Preview" issue. My two cents on multi-stakeholder commercial models.
Directly blog
bottom of page